These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
786 related articles for article (PubMed ID: 31336149)
1. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver. Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149 [TBL] [Abstract][Full Text] [Related]
2. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance. Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047 [TBL] [Abstract][Full Text] [Related]
3. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling. Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180 [TBL] [Abstract][Full Text] [Related]
4. The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes. Hörbelt T; Tacke C; Markova M; Herzfeld de Wiza D; Van de Velde F; Bekaert M; Van Nieuwenhove Y; Hornemann S; Rödiger M; Seebeck N; Friedl E; Jonas W; Thoresen GH; Kuss O; Rosenthal A; Lange V; Pfeiffer AFH; Schürmann A; Lapauw B; Rudovich N; Pivovarova O; Ouwens DM Diabetologia; 2018 Sep; 61(9):2054-2065. PubMed ID: 29754289 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway. Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813 [TBL] [Abstract][Full Text] [Related]
6. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice. Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348 [TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis. Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663 [TBL] [Abstract][Full Text] [Related]
8. Physiological Disturbance in Fatty Liver Energy Metabolism Converges on IGFBP2 Abundance and Regulation in Mice and Men. Fahlbusch P; Knebel B; Hörbelt T; Barbosa DM; Nikolic A; Jacob S; Al-Hasani H; Van de Velde F; Van Nieuwenhove Y; Müller-Wieland D; Lapauw B; Ouwens DM; Kotzka J Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532003 [TBL] [Abstract][Full Text] [Related]
9. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects. Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115 [TBL] [Abstract][Full Text] [Related]
10. Adipokinome Signatures in Obese Mouse Models Reflect Adipose Tissue Health and Are Associated with Serum Lipid Composition. Knebel B; Fahlbusch P; Poschmann G; Dille M; Wahlers N; Stühler K; Hartwig S; Lehr S; Schiller M; Jacob S; Kettel U; Müller-Wieland D; Kotzka J Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137678 [TBL] [Abstract][Full Text] [Related]
11. Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis. Vázquez-Borrego MC; Del Río-Moreno M; Pyatkov M; Sarmento-Cabral A; Mahmood M; Pelke N; Wnek M; Cordoba-Chacon J; Waxman DJ; Puchowicz MA; McGuinness OP; Kineman RD Metabolism; 2023 Jul; 144():155589. PubMed ID: 37182789 [TBL] [Abstract][Full Text] [Related]
12. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice. Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289 [TBL] [Abstract][Full Text] [Related]
14. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094 [TBL] [Abstract][Full Text] [Related]
15. Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease. Shannon CE; Ragavan M; Palavicini JP; Fourcaudot M; Bakewell TM; Valdez IA; Ayala I; Jin ES; Madesh M; Han X; Merritt ME; Norton L Mol Metab; 2021 Mar; 45():101154. PubMed ID: 33359401 [TBL] [Abstract][Full Text] [Related]
16. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis. Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855 [TBL] [Abstract][Full Text] [Related]
17. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis. Tong X; Li P; Zhang D; VanDommelen K; Gupta N; Rui L; Omary MB; Yin L J Lipid Res; 2016 Jul; 57(7):1219-30. PubMed ID: 27252523 [TBL] [Abstract][Full Text] [Related]
18. Menin regulates lipid deposition in mouse hepatocytes via interacting with transcription factor FoxO1. Wang S; Liu T; Sun L; Du H; Xu Z; Li R; Yu Y; Mao Y; Shi K Mol Cell Biochem; 2022 May; 477(5):1555-1568. PubMed ID: 35182330 [TBL] [Abstract][Full Text] [Related]